Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Interactions
  4. Cardiology
  5. Antiplatelets/Anticoagulants
  6. Apixaban

Apixaban

  • Bone & Joint (71)
  • Cardiology (293)
    • Antiarrhythmics (82)
    • Antihypertensives (93)
    • Antiplatelets/Anticoagulants (145)
      • Apixaban (18)
      • Aspirin (34)
      • Clopidogrel (44)
      • Dabigatran (23)
      • Edoxaban (10)
      • Rivaroxaban (12)
      • Ticagrelor (9)
      • Vorapaxar (2)
      • Warfarin (97)
    • Dyslipidemia Drugs (72)
    • Other (21)
  • Dermatology (56)
  • Diabetes & Endocrinology (46)
  • Gastroenterology (87)
  • Hematology & Oncology (6)
  • Infectious Diseases (249)
  • Men's Health (3)
  • Natural Medicines / Supplements / Food Interactions (151)
  • Neurology (134)
  • Nutrition & Obesity (9)
  • Psychiatry (153)
  • Resources (44)
  • Respiratory & Allergy (16)
  • Transplant Meds (17)
  • Women's Health (53)
1 - 15 of 18 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and More
May 2024
Article: Know Which DOAC Interactions Require a Med Change May 2023
Chart: Comparison of Oral Anticoagulants March 2023
Technician Tutorial: Dispensing Oral Blood Thinners November 2022
Article: Help Ensure Appropriate DOAC Dosing August 2022
Toolbox: Appropriate Use of Oral Anticoagulants June 2022
Article: Expect to See DOACs for Venous Thromboembolism Due to Cancer June 2020
Chart: P-glycoprotein Drug Interactions June 2020
Article: Consider It a Red Flag if You See a Direct Oral Anticoagulant Plus Warfarin February 2019
Chart: Bridging Warfarin February 2019
Article: Explain Risks and Benefits of Medical Marijuana September 2017
Article: Weigh Antithrombotic Risks and Benefits for Atrial Fib Patients With CAD November 2016
Chart: Canadian Atrial Fibrillation Guidelines: Focus on Pharmacotherapy November 2016
Guideline: Management of Atrial Fibrillation: Complete Guidelines Listing (2016) November 2016
Article: Look for Atrial Fib Patients Who May Need Anticoagulation October 2016
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved